-
-
-
-
-
-
-
Agenus completes $141 million Zydus collaboration deal
-
-
-
-
-
-
-
AGENUS gets french compassionate access for cancer drug combination
-
-
-
-
-
-
-
Agenus drug combo shows 42% two-year survival in colorectal cancer trial
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Neutral Rating on Agenus Inc. (AGEN)
-
-
-
-
-
-
-
Agenus (AGEN) Secures $22M Mortgage and Announces Strategic Operational Realignment
-
-
-
-
-
-
-
Agenus (AGEN): BMS is returning AGEN1777 back to Agenus
-
-
-
-
-
-
-
Agenus (AGEN) Announces End-of-Phase-2 Meeting Outcomes and Topline Interim Phase 2 Data for BOT/BAL in MSS Colorectal Cancer
-
416,808 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

